Additionally, semaglutides effect on lowering blood glucose levels can sometimes lead to hypoglycemia, a condition where the brain does not receive enough glucose, causing dizziness
High-risk individuals may receive more long-term cardiovascular protection if GLP-1 RAs are initiated earlier
In the short term, however, a too rapid reduction in blood sugar (HbA1c value), as is often achieved with Ozempic, can be dangerous
Understanding Tirzepatide: Originally developed for type 2 diabetes, tirzepatide is a breakthrough injectable medication that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors to manage glucose levels
For many people, diet and exercise alone aren't enough to overcome the complex biological factors that contribute to weight gain
Carnitine panel was abnormal in half of the patients in whom it was measured with 33% of the patients having high-esterified carnitine and 17% having low free carnitine